For patients hospitalized for COVID-19, administration of therapeutic-dose vs prophylactic-dose anticoagulation with heparins ...
Objective. To provide the pediatric intensivist an in-depth understanding of citrate as regional anticoagulant during continuous renal replacement therapy. Data Sources and Data Selection.
Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...
Much of the research in optimizing anticoagulant therapy for acute VTE has been carried out in patients without malignancies. Given the aggressive natural history of VTE in cancer patients ...
The researchers found that 28-day mortality was reduced with therapeutic-dose versus prophylactic-dose anticoagulation with heparins (odds ratio, 0.77; 95 percent confidence interval, 0.64 to 0.93 ...
Fewer thromboembolic events were seen in association with higher- vs lower-dose anticoagulation, but the risk for major bleeding was greater. (HealthDay News) — For patients hospitalized for ...
During a Case-Based Roundtable® event, Joshua K. Sabari, MD, continued discussion of key outcomes from the MARIPOSA trial and ...
Acute coronary syndrome (ACS) is a term used to describe a range of conditions resulting from the sudden reduction or ...
Submission of a Prior Approval Supplement for a reduction in the number of patients in the NEPHRO CRRT study is expected within ...
Talphera (TLPH) announced that following a meeting with the FDA, the agency has agreed to review a Prior Approval Supplement requesting a ...